SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-304002
Filing Date
2021-10-21
Accepted
2021-10-21 16:09:46
Documents
15
Period of Report
2021-10-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d179221d8k.htm   iXBRL 8-K 59863
2 EX-10.1 d179221dex101.htm EX-10.1 66770
3 EX-99.1 d179221dex991.htm EX-99.1 21268
7 GRAPHIC g179221page1.jpg GRAPHIC 5216
  Complete submission text file 0001193125-21-304002.txt   320140

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA atha-20211018.xsd EX-101.SCH 2871
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE atha-20211018_lab.xml EX-101.LAB 18888
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atha-20211018_pre.xml EX-101.PRE 11846
8 EXTRACTED XBRL INSTANCE DOCUMENT d179221d8k_htm.xml XML 3477
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Filer) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39503 | Film No.: 211337116
SIC: 2836 Biological Products, (No Diagnostic Substances)